文献速递急性肾损伤

Meta分析何时能得出结论?试验序贯分析指南及心脏手术远程缺血预适应肾脏保护示例

When is a meta-analysis conclusive? A guide to Trial Sequential Analysis with an example of remote ischemic preconditioning for renoprotection in patients undergoing cardiac surgery.
PubMed 文献 · Nephrol Dial Transplant · 2017-01-01

本文解释并示例试验序贯分析(TSA)如何判断Meta分析是否可得出结论。常规Meta分析显示,在成人心脏手术患者中,远程缺血预适应未显著降低急性肾损伤(12项试验,4230例;相对危险度0.87,95%CI 0.74-1.02;P=0.08;I²=35%)或接受急性透析的风险(5项试验,2111例;相对危险度1.15,95%CI 0.42-3.19;P=0.78;I²=59%)。TSA表明急性肾损伤相对风险降低20%已不太可能,可靠检出透析及更小效应需更多证据。

要点

  • 常规Meta分析显示远程缺血预适应未显著降低心脏手术患者急性肾损伤风险(RR 0.87,95%CI 0.74-1.02;P=0.08)。
  • TSA表明急性肾损伤相对风险降低20%已不太可能,可靠检出透析及更小效应需更多证据。
  • 在两个较早时间点进行的常规Meta分析可能过早宣称急性肾损伤显著降低,而TSA全程无充分证据支持该效应。

核心结论

  • TSA可防止Meta分析得出过早结论。

研究设计与样本

  • 本文为方法学指南与示例,采用常规Meta分析及试验序贯分析(TSA)解读Meta分析结论。

主要发现

  • 常规Meta分析显示,在成人心脏手术患者中,远程缺血预适应未显著降低急性肾损伤(12项试验,4230例;相对危险度0.87,95%CI 0.74-1.02;P=0.08;I²=35%)。
  • 常规Meta分析显示,远程缺血预适应未显著降低接受急性透析的风险(5项试验,2111例;相对危险度1.15,95%CI 0.42-3.19;P=0.78;I²=59%)。
  • TSA表明急性肾损伤相对风险降低20%已不太可能,可靠检出急性透析效应及更小的急性肾损伤效应需更多证据。
  • 在两个较早时间点进行的常规Meta分析可能过早宣称急性肾损伤显著降低,而TSA全程无充分证据支持该效应。

关键数值与推荐

  • 急性肾损伤:12项试验,4230例;相对危险度0.87(95%CI 0.74-1.02);P=0.08;I²=35%。
  • 接受急性透析风险:5项试验,2111例;相对危险度1.15(95%CI 0.42-3.19);P=0.78;I²=59%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Regardless of whether a randomized trial finds a statistically significant effect for an intervention or not, readers often wonder if the trial was large enough to be conclusive. To answer this question, we can estimate the required sample size for a trial by considering how commonly the outcome occurs, the smallest effect of clinical importance and the acceptable risk of falsely detecting or rejecting that effect. But when is a meta-analysis conclusive? We explain and illustrate the interpretation of Trial Sequential Analysis (TSA), a method increasingly used to answer this question. We conducted a conventional meta-analysis which suggested that, in adults undergoing cardiac surgery, remote ischemic preconditioning does not provide a statistically significant reduction in acute kidney injury (AKI) [12 trials, 4230 patients; relative risk 0.87 (95% confidence interval 0.74-1.02); P = 0.08; I2= 35%] or the risk of receiving acute dialysis [5 trials, 2111 patients; relative risk 1.15 (95% confidence interval 0.42-3.19); P = 0.78; I2 = 59%]. TSA demonstrates that as little as a 20% relative risk reduction in AKI is unlikely. Reliably finding effects on acute dialysis and smaller effects on AKI would require much more evidence. Notably, conventional meta-analyses conducted at one of the two earlier time points may have prematurely declared a statistically significant reduction in AKI, even though at no point in the TSA was there sufficient evidence to support such an effect. With this and other examples, we demonstrate that the TSA can prevent premature conclusions from meta-analyses.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. Roshanov PS, Dennis BB, Pasic N, et al. When is a meta-analysis conclusive? A guide to Trial Sequential Analysis with an example of remote ischemic preconditioning for renoprotection in patients undergoing cardiac surgery. Nephrol Dial Transplant. 2017. PMID: 28380638. doi:10.1093/ndt/gfw219

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。